Skip to main content
Conavi Medical Corp. logo

Conavi Medical Corp. — Investor Relations & Filings

Ticker · CNVI TSXV Manufacturing
Open in API
Filings indexed 346 across all filing types
Latest filing 2024-12-10 Investor Presentation
Country CA Canada
Listing TSXV CNVI

About Conavi Medical Corp.

https://www.conavi.com/

Conavi Medical Corp. is a medical device company focused on designing, manufacturing, and marketing image guidance technologies for minimally invasive cardiovascular procedures. Its flagship product is the Novasight Hybrid System, which provides simultaneous, co-registered Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) imaging using a single catheter and pullback. This hybrid approach offers comprehensive visualization of coronary arteries, combining the high resolution of OCT for lumen assessment with the depth of IVUS for vessel wall analysis. The system is intended to guide complex Percutaneous Coronary Interventions (PCIs) by providing additional diagnostic information over single-modality imaging.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Investor Presentation Classification · 1% confidence The document is a press release announcing that Conavi Medical’s CEO will present the company’s business update at the MedInvest MedTech, AI & Digital Health Conference, with details on webcast timing and where to access it. It is neither a financial report nor a regulatory filing but rather an announcement of an investor presentation event. Therefore, it falls under the Investor Presentation category (IP).
2024-12-10 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a short press release announcing regulatory approval by China’s NMPA which triggers a final US$5.9 million milestone payment under a licensing agreement. The company will use the proceeds to extinguish its promissory note, representing a debt repayment and capital structure change. It is not an earnings release, annual/interim report, management change, or regulatory report publication; instead it details a financing activity (milestone receipt and debt extinguishment). Therefore, it fits the Capital/Financing Update category.
2024-12-10 English
News release - English.pdf
Regulatory Filings Classification · 0% confidence The document is a corporate press release (via Globe Newswire) announcing the publication of a peer-reviewed article about Conavi Medical’s imaging technology. There are no financial results, board changes, proxy materials, dividends, M&A, or other regulated report types. It is not an earnings release, annual/interim report, investor presentation, or notice of dividend/share issuance. It is essentially a general corporate news announcement, which falls into the fallback category of Regulatory Filings (RNS).
2024-12-10 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release announcing Conavi Medical’s engagement of ICP Securities for automated market making services. It is not a financial report, management change, dividend notice, share issuance, or any other specific filing category. It serves as a general regulatory announcement of a corporate development. Therefore, it best fits the fallback category “Regulatory Filings” (RNS).
2024-12-10 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2024-11-14 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2024-11-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.